MBF Therapeutics Inc. (MBFT) is a veterinary oncology company developing innovative and highly effective immunotherapies for cancer and infectious diseases in companion animals and livestock. Our proprietary checkpoint inhibitor technology, based on the Wistar Institute’s intellectual property, is a platform technology from which multiple innovative prophylactic and therapeutic products will be developed for animal health markets worth over $5BM. We are working with Dr. Hildegund Ertl at the Wistar Institute and veterinary oncologists to develop a cancer vaccine to treat dogs with melanoma.
http://www.mbftherapeutics.com/
ttillett@mbftherapeutics.com